Summary of Significant Accounting Policies (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Significant Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Company's Revenue | The following table summarizes the Company’s revenue for the three months ended March 31, 2026 and 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Common Stock Issuable Upon Vesting and Exercise | The table below provides information on shares of the Company’s common stock issuable upon vesting and exercise, as of March 31:
|
|||||||||||||||||||||||||||||||||||||||||||||||